Cargando…
Combination Therapy of Navitoclax with Chemotherapeutic Agents in Solid Tumors and Blood Cancer: A Review of Current Evidence
Combination therapy emerges as a fundamental scheme in cancer. Many targeted therapeutic agents are developed to be used with chemotherapy or radiation therapy to enhance drug efficacy and reduce toxicity effects. ABT-263, known as navitoclax, mimics the BH3-only proteins of the BCL-2 family and has...
Autores principales: | Nor Hisam, Nur Syahidah, Ugusman, Azizah, Rajab, Nor Fadilah, Ahmad, Mohd Faizal, Fenech, Michael, Liew, Sze Ling, Mohamad Anuar, Nur Najmi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468743/ https://www.ncbi.nlm.nih.gov/pubmed/34575429 http://dx.doi.org/10.3390/pharmaceutics13091353 |
Ejemplares similares
-
Clinical Review: Navitoclax as a Pro-Apoptotic and Anti-Fibrotic Agent
por: Mohamad Anuar, Nur Najmi, et al.
Publicado: (2020) -
Evaluating the Potential of Plukenetia volubilis Linneo (Sacha Inchi) in Alleviating Cardiovascular Disease Risk Factors: A Mini Review
por: Abd Rahman, Izzat Zulhilmi, et al.
Publicado: (2023) -
Persicaria minor (Huds.) Opiz Prevents In Vitro Atherogenesis by Attenuating Tumor Necrosis Factor-α-Induced Monocyte Adhesion to Human Umbilical Vein Endothelial Cells
por: Hamid, Adila A., et al.
Publicado: (2022) -
Exploring the Relationship of Perivascular Adipose Tissue Inflammation and the Development of Vascular Pathologies
por: Rami, Afifah Zahirah Abd, et al.
Publicado: (2022) -
The Role of Polyphenol in Modulating Associated Genes in Diabetes-Induced Vascular Disorders
por: Mohd Nor, Nor Anizah, et al.
Publicado: (2022)